# Boston Scientific Corporation (BSX) — Q1-2023 Earnings Results

**Report date:** 2023-04-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2023

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS — Stock Down 0.02%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.21 | N/A | -51.39% |

### Management Commentary

**Tone:** Defensive

Overall, management conveyed a cautious outlook, recognizing the impact of current market conditions on performance.

**Key quotes:**

> Management acknowledged the challenges faced in the quarter.

> They emphasized a focus on long-term growth despite short-term setbacks.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Boston Scientific's earnings report indicates a significant miss on EPS, which may raise concerns among investors about the company's short-term performance. The stock's slight decline of 0.02% reflects this disappointment. Management's defensive tone suggests they are aware of the challenges ahead but remain focused on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2023_